In the central nervous system (CNS) of adult mammals, neurogenesis occurs in only two restricted areas, the subgranular zone (SGZ) of the hippocampus and the subventricular zone (SVZ). Isolation of multipotent progenitor cells from other CNS regions suggests that their neurogenic potential is dictated by local environmental cues. Here, we report that astrocytes in areas outside of the SGZ and SVZ of adult mice express high levels of ephrin-A2 and -A3, which present an inhibitory niche, negatively regulating neural progenitor cell growth. Adult mice lacking both ephrin-A2 and -A3 display active ongoing neurogenesis throughout the CNS. These findings suggest that neural cell replacement therapies for neurodegeneration or injury in the adult CNS may be achieved by manipulating ephrin signaling pathways.
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astrocytes ͉ neural stem cells ͉ stem cell niche ͉ non-neurogenic region I n the CNS of adult mammals, regions outside of the subgranular zone (SGZ) and subventricular zone (SVZ) do not exhibit constitutive neurogenesis under normal conditions in vivo, although limited neurogenesis can be induced in vivo by injury-induced signals (1) or by specific cues (2) (3) (4) . To date, the mechanisms that control neurogenesis in discrete regions of the adult CNS remain unclear. Isolation of progenitor cells from regions outside of the SGZ and SVZ that showing a capacity for generating neurons and glial cells, at least when examined ex vivo, suggests that quiescent neural stem cells are widely distributed in the adult CNS (4) . Compelling evidence indicates that glial fibrillary acidic protein (GFAP)-positive cells of astroglial origin constitute a primary source of neural progenitors in the SGZ and SVZ (5) (6) (7) . These cells are in intimate contact with endothelial cells and astrocytes (8, 9) , which helps to generate an instructive niche that promotes progenitor cell proliferation and differentiation (10) . Importantly, astrocytes isolated from different CNS regions exhibit regional heterogeneity with regard to their ability to support progenitor cell growth (11) . Astrocytes isolated from the SVZ and SGZ, namely niche astrocytes, support neurogenesis by creating an instructive niche; whereas astrocytes derived from nonneurogenic CNS regions seem to be inhibitory for stem cell growth (8) . These observations raise the possibility that nonneurogenic CNS areas may present a prohibitive niche that prevents neurogenesis in the adult.
Ephrins and Eph receptors are pivotal regulators of pattern formation, cell migration, axonal guidance, and synaptogenesis during CNS development (12) . Recent studies indicate that ephrin-A2 and -A5, and their receptor EphA7, regulate neural stem cell survival and proliferation in the developing telencephalon (13) , and mediate antiproliferative effects in the adult SVZ (14) . To identify negative regulators of neurogenesis acting outside the conventional neurogenic regions (the SVZ and SGZ), we screened molecules for antiproliferative effects on neural progenitor cells. We found that astrocytes from nonneurogenic CNS regions express high levels of ephrin-A2 and -A3. Addition of antibody-clustered ephrin-A2 and -A3 in culture inhibited neural progenitor cell proliferation without affecting cell survival. Adult mice deficient in both ephrin-A2 and -A3 showed robust neurogenesis in diverse CNS regions. These findings suggest that activation of an endogenous source of neural progenitors through manipulation of ephin signaling may facilitate cell replacement therapies in CNS injury and disease.
Results

Isolation of Neural Progenitors from Nonneurogenic CNS Areas of
Adult Mice. We carried out a series of coculture experiments to test the idea that multipotent progenitor cells are present in diverse regions of the adult CNS, and that they can be stimulated to form neurospheres-spherical cell clusters formed by neural stem cells-in culture. Dissociated cells from nonneurogenic CNS regions, including the cerebral cortex (excluding the SVZ), spinal cord and cerebellum, were cocultured with niche astrocytes isolated from neonatal (P0) mouse brain. Because both the adult SGZ and neonatal mouse brains actively undergo neurogenesis in vivo, their astrocytes are considered to present an instructive niche that is permissive for progenitor cell growth and neurosphere formation in culture (15) . To distinguish different cell populations in cocultures, either CNS cells or astrocytes were isolated from transgenic (tg) mice carrying the green fluorescence protein (GFP) transgene driven by a chicken ␤-actin promoter (GFPtg) (16) . In control experiments, niche astrocytes were replaced either with NIH 3T3 fibroblasts, age-matched cortical cells of adult mice, or no cells at all.
After 8-14 days, dissociated nonneurogenic cells that were cocultured with P0 brain astrocytes developed numerous neurospheres that were labeled positive for neural progenitor cell markers, BrdU (proliferation marker) and nestin [supporting information (SI) Fig. S1a ]. In contrast, control cultures that were seeded either with NIH 3T3 fibroblasts or without any cells generated few neurospheres or colonies (Fig. S1a) . The number of neurospheres in cultures plated in the presence of SGZ or P0 brain astrocytes was 5-to 15-fold higher than those of control groups ( Fig. 1 a and b) , suggesting that neural progenitor-like cells exist in diverse CNS regions. Moreover, when niche astrocytes were GFP ϩ , all neurospheres were GFP-negative. Vice versa, when niche astrocytes were GFP Ϫ , neurospheres were GFP ϩ , indicating that neurospheres were derived from dissociated cell populations isolated from nonneurogenic regions.
To confirm the self-renewing ability of neurosphere-derived cells, neurospheres were dissociated; the resulting cells were plated as single cell suspensions to assay for their ability to develop new spheres. We noted that new neurospheres were generated even after 10 passages without diminution of sphere-forming ability. To determine the multipotency and induce differentiation in these cells, individual secondary or tertiary spheres derived from single cell suspensions were dissociated and plated onto matrigel-coated coverslips. Sphere-derived cells readily attached and were capable of differentiating into either neurons or glial cells (Fig. S1b) . After 7 days in culture, sphere-derived cells expressed markers for neurons (Tuj1; 5 Ϯ 2.3%), oligodendrocytes (O4; 7 Ϯ 3.5%) and astrocytes (GFAP; 12 Ϯ 5.1%). These results demonstrate that multipotent neural progenitor cells are present in many areas of the CNS that were previously considered to be nonneurogenic.
To further test the hypothesis that astrocytes from nonneurogenic regions of the adult CNS inhibit neurogenesis, we cocultured sphere-derived neural progenitor cells with astrocytes isolated from a nonneurogenic region, the neocortex of adult mice. Fluorescence activated cell sorting (FACS) was performed to isolate adult cortical astrocytes (GFP ϩ ) from transgenic mice in which the expression of GFP is driven by a GFAP promoter (GFAP-GFP) (17) (Fig. S1c) . After 8 days of incubation, neural progenitor cells plated in the same wells with niche astrocytes developed significantly more neurospheres than those of control cultures in which no feeder cells were added. Progenitor cells plated in the same wells with adult cortical astrocytes, in contrast, exhibited reduced number of neurospheres as compared with controls (Fig. 1c) . These results indicate that adult nonneurogenic astrocytes differ from SGZ or P0 astrocytes in that they present signals that actively inhibit the survival or proliferation of neural progenitors.
Ephrin-A2 and -A3 Are Key Negative Regulators of Adult Neural
Progenitors. To identify the inhibitory signals present in nonneurogenic CNS astrocytes, we screened for molecules reportedly associated with neurogenesis that are differentially expressed by cells or astrocytes from neurogenic versus nonneurogenic regions of adult mice. Astrocytes were isolated from GFAP-GFP mice by FACS. Expression of bone morphogen proteins (18), wnt and wnt inhibitors (19, 20) , ephrin-As and -Bs (13, 14, 21) , and other molecules were compared by using RT-PCR and Western blotting. The ability of these candidates to inhibit neurosphere formation was then analyzed by using cortical-niche astrocyte cocultures.
Our screening yielded two candidates, ephrin-A2 and -A3, whose expression was high in astrocytes of the adult cerebral cortex, but low in those derived from the neurogenic SGZ of adult mice (Fig.  2a) . Immunolabeling further indicated that expression of these two molecules was primarily associated with nonneurogenic astrocytes; both ephrin-A2 and -A3 colocalized with the astrocyte marker GFAP, but not with the neuronal marker NeuN or oligodendrocyte marker RIP (Fig. 2b) . Functional screening assays also revealed that addition of dissociated cortical-niche astrocyte cocultures with antibody-clustered forms of ephrin-A2 and -A3 significantly decreased the number of neurospheres (Fig. 2c) . Antibody-clustering was used because activation of Eph receptors requires binding with clustered forms of ephrins in the cell membrane, whereas unclustered forms of ephrins bind receptors but function as antagonists of Eph signaling (22) . To determine whether ephrin-A2 and -A3 regulate neural progenitor cell proliferation or cell survival, we compared BrdU incorporation and TdT-mediated dUTP nick end labeling (TUNEL) in neurosphere-derived progenitor cell cultures. Incubation with clustered ephrin-A2 or -A3 significantly reduced BrdU incorporation (Fig. 2d) , whereas there was no effect on the number of TUNEL-positive cells (Fig. 2e) . These data indicate that ephrin-A2 and -A3 inhibit neural progenitor proliferation without affecting cell survival.
Neural Progenitor Proliferation in Nonneurogenic CNS Regions of
Adult A2 ؊/؊ A3 ؊/؊ Mice. We hypothesized that if ephrin-A2 and -A3 were key inhibitors of adult neurogenesis, absence of ephrin-A2 and -A3 would lead to robust progenitor cell proliferation in nonneurogenic regions of the adult CNS in vivo. We used mice deficient in both ephrin-A2 and -A3 (A2 Ϫ/Ϫ A3 Ϫ/Ϫ ) (23, 24) . Three days after BrdU pulse-labeling, dividing neural progenitors were detected in the cerebral cortex of adult A2 Ϫ/Ϫ A3 Ϫ/Ϫ mice (Fig. 3a) . These cells were coimmunostained for BrdU and another proliferating cell marker Ki67, or the neural progenitor cell marker nestin (Fig. S2) . At least 62 Ϯ 4.5% BrdU-positive cells were nestin-positive neural progenitors. In contrast, BrdU ϩ /Ki67 ϩ /nestin ϩ cells in wild-type (WT) mice were limited to the SGZ and SVZ, with very few evident in the cerebral cortex or other CNS areas (Fig. 3a) . There was a 6-fold increase of BrdU ϩ /nestin ϩ proliferating neural progenitors in the cortex of adult A2 Ϫ/Ϫ A3 Ϫ/Ϫ mice ( Fig. 3b ) and, associated with it, a significant increase in cortical areas as compared with WT mice (Fig. 3c ). This increase of progenitor cell proliferation could be observed at as early as P14 in A2 Ϫ/Ϫ A3 Ϫ/Ϫ mice (Fig. S3a) . Moreover, a drastic increase of progenitor cell proliferation was also counted from diverse nonneurogenic CNS regions of adult A2 Ϫ/Ϫ A3 Ϫ/Ϫ mice, including the midbrain, hindbrain, cerebellum, and spinal cord (Fig. S3b) . As expected, the absence of ephrin-A2 and -A3 also led to a significant enhancement of neural progenitor proliferation in the SGZ of adult A2 Ϫ/Ϫ A3 Ϫ/Ϫ mice as compared with WT mice (Fig. 3d) .
Next, we asked whether neural progenitors isolated from either neurogenic or nonneurogenic CNS regions of A2 Ϫ/Ϫ A3 Ϫ/Ϫ mice had increased proliferative potential in culture. Dissociated SGZ and cortical cells derived from WT and A2 Ϫ/Ϫ A3 Ϫ/Ϫ mice were cultured as described above but in the absence of niche astrocytes. After 7 days of incubation, cultures derived from the neocortex or SGZ of A2 Ϫ/Ϫ A3 Ϫ/Ϫ mice developed significantly higher numbers of neurospheres than those of WT mice (Fig. 3e) . Addition of clustered ephrin-A2 and -A3 to the cultures derived from A2 Ϫ/ ϪA3 Ϫ/Ϫ mice led to reduced numbers of neurospheres (Fig. 3f ) , suggesting that increased formation of neurospheres in these cultures was a result of ephrin-A2 and -A3-deficiency. This result was then confirmed by examining BrdU incorporation in culture (data not shown). Collectively, these studies identified ephrin-A2 and -A3 as previously undescribed regulators of neural progenitor cell proliferation in the adult CNS.
To determine whether the presence of both ephrin-A2 and -A3 is required to inhibit progenitor cell proliferation, we also analyzed ephrin-A2 (A2 Ϫ/Ϫ ) or ephrin-A3 (A3 Ϫ/Ϫ ) single mutant mice. Counts of BrdU ϩ cells after BrdU-pulse labeling revealed that both A2 Ϫ/Ϫ and A3 Ϫ/Ϫ mice exhibited significantly increased cell proliferation in their nonneurogenic (e.g., cortex; Fig. 3b ) and neurogenic (e.g., SGZ; Fig. 3d) brain regions as compared with WT mice ( Fig. 3 b-d) . There was Ϸ6-to 7-fold increase of proliferating neural progenitors found in nonneurogenic brain regions of A2 Ϫ/Ϫ and A3 Ϫ/Ϫ mice as compared with WT mice. These data suggest that ephrin-A2 and -A3 are at least partly redundant in their regulation of progenitor cell proliferation in vivo. Moreover, TUNEL labeling of brain sections indicated no significant difference in cell apoptosis among adult WT, A2 Ϫ/Ϫ , A3 Ϫ/Ϫ , and A2 Ϫ/Ϫ A3 Ϫ/Ϫ mice (Fig. 3g) , indicating that BrdU incorporation in mutant mice was not due to increased apoptosis. Ϫ/Ϫ mice received daily injections of BrdU for 7 days and were killed 14 days after the first BrdU injection. Brain sections were double-labeled by primary antibodies against BrdU and the neuroblast cell marker DCX (25) or the early neuronal marker ␤III-tubulin (Tuj1) (26) . In adult WT mice, neurogenesis had long ceased in nonneurogenic brain regions; cells highly expressing DCX (Fig. 4a) and ␤III-tubulin (Fig. 4 e and g ) were restricted to the SZG and SVG. In agreement with previous reports (27, 28) , a few could be found in the gray matter of the neocortex, primarily near the region of the corpus callosum. Strikingly, in adult A2 Ϫ/Ϫ A3 Ϫ/Ϫ mice, brightly labeled DCX ϩ (Fig. 4 b-d) and ␤III-tubulin ϩ (Fig. 4  f and h ) neurons and neurites were seen in cortical sections as well as in other nonneurogenic CNS regions (Fig. S3c) , suggestive of ongoing neurogenesis. We detected Ͼ10-fold increases in the number of cells immunopositive for DCX (Fig. 4i) or ␤III-tubulin (Fig. 4j) in the neocortex of adult A2 Ϫ/Ϫ A3 Ϫ/Ϫ mice as compared with that of WT mice. Consistent with this observation, a significant increase in the number of DCX ϩ and ␤III-tubulin ϩ cells was found in the SGZ of adult A2 Ϫ/Ϫ A3 Ϫ/Ϫ mice when compared with WT mice (Fig. S4) . Many DCX ϩ cells in the SGZ revealed a morphology that resembled proliferating neuroblasts, with short cellular processes oriented parallel to the dentate granule cell layer (25) .
To further prove that the increase of DCX expression in the CNS of adult A2 Ϫ/Ϫ A3 Ϫ/Ϫ mice reflects an ongoing neurogenesis, we carried out a time course study quantifying cells double-labeled for DCX and BrdU in mice receiving daily injections of BrdU for 14 consecutive days. Results of cell counts indicated a continuing increase in the percentage of DCX ϩ cells incorporating BrdU, from day 1 to 14 after the first BrdU injection (Fig. 4k) , suggesting that DCX ϩ cells were newly generated neurons. These data strongly support the notion that removal of ephrin-A2 and -A3 promotes not only neural progenitor cell proliferation, but also neural differentiation and adult neurogenesis in vivo.
To determine whether neural progenitors in A2 Ϫ/Ϫ A3 Ϫ/Ϫ mice terminally differentiate into neurons or glia, we quantified the number of BrdU ϩ cells expressing the mature neuronal and glial markers, MAP2 and GFAP. Antibodies recognizing the neuronal nuclear markers, NeuN and HuD (1), were used to enable accurate and unequivocal demonstration of neuronal differentiation. Two weeks after BrdU injection, many BrdU ϩ cells in A2 Ϫ/Ϫ A3 Ϫ/Ϫ mice expressed MAP2, HuD, NeuN or GFAP (Fig. 4l and Fig. 5 ). Consistent with that BrdU ϩ cells had recently exited the cell cycle, we found more BrdU ϩ cells that were labeled by anti-HuD, an immature neuronal marker, than by antibody recognizing a mature neuronal marker, NeuN (Fig. 4l) (26) . These results demonstrate that ephrin-A2 and -A3 are key inhibitory signals that block neurogenesis in nonneurogenic regions of the adult CNS.
Ephrin-A2 and -A3 Activate EphA7-Mediated Forward Signaling to
Inhibit Neural Progenitor Proliferation. The receptor for ephrin-A ligands, EphA7, controls progenitor cell proliferation by interacting with ephrin-A2 in the adult SVZ (14) . We thus asked whether ephrin-A2 and -A3 signal through EphA7 to inhibit progenitor cell proliferation in nonneurogenic CNS regions. Expression of EphA7 in the cerebral cortex of adult mice and in neural progenitor cells derived from nonneurogenic brain regions was confirmed by Western blot and immunohistochemistry (Fig. S5 a and b) . EphA7 expression correlated with that of ephrin-A2 and -A3, which was higher in nonneurogenic CNS regions and lower in the SGZ. Binding of ephrin-A2 and -A3 to EphA7 was demonstrated by coimmunoprecipitation from cell lysates derived from cortical neural progenitor cells (Fig. S5a) .
To determine whether ephrin-A2 and -A3 inhibit progenitor cell proliferation by activating EphA7-mediated signaling, we examined ephrin-induced EphA7 phosphorylation. Upon activation, EphA7 suppresses the phosphorylation of extracellular-signal-regulated m (a, b, e, and f ) and 10 m (c, d, g, and h ).] (i and j) Counts of DCX ϩ (i) and Tuj-1 ϩ (j) cells per 1,000 nuclei in cortical sections of adult WT (n ϭ 5) and A2 Ϫ/Ϫ A3 Ϫ/Ϫ mice (n ϭ 6). protein kinase (ERK). Administration of clustered ephrin-A2 and -A3 to cortical neural progenitor cell cultures induced EphA7 phosphorylation (Fig. S5c ) and led to a reduction in ERK phosphorylation (Fig. S5d) . In contrast, expression in cortical neural progenitors of a truncated form of EphA7 (EphA7-T1), in which the intracellular domain of EphA7 is absent, attenuated clustered ephrin-A2-mediated or ephrin-A3-mediated EphA7 phosphorylation (Fig. S5e) . Moreover, expression of EphA7-T1 blocked ephrin-A2-mediated and ephrin-A3-mediated inhibition of progenitor proliferation in culture (Fig. S5f) . Together, these data indicate that ephrin-A2 and -A3 activate EphA7 to inhibit neural progenitor cell proliferation.
Discussion
This study identifies ephrin-A2 and -A3 as key components of the niche that inhibits neural progenitor cell proliferation and differentiation in nonneurogenic regions in the adult brain. Normally, constitutive neurogenesis is limited to discrete CNS regions in the adult. Deletion of ephrin-A2 and -A3 permits neurogenesis in diverse regions of the adult CNS in vivo. Interestingly, most newly generated neurons seemed to be GABAergic (data not shown). The data suggest a previously undescribed mechanism of activating the endogenous source of neural progenitors for neuroregeneration and replacement therapy. In addition, we provide evidence suggesting that ephrin-A2 and -A3 act through receptor EphA7 to mediate progenitor cell growth. Further experiments are required to address the relative contributions of ephrin-A2 and -A3 to the proliferation and differentiation of neural progenitors and to unravel the signaling pathways through which ephrins mediate neural progenitor cell growth.
Emerging evidence suggests a role for astrocytes in controlling adult neurogenesis, from proliferation and fate specification of neural progenitors to migration and integration of neural progeny into the brain circuits (8) . In neurogenic regions, SGZ astrocytes are in intimate contact with neural progenitors and produce both membrane-bound and soluble factors that stimulate neural progenitors to reenter the cell cycle and adopt a neuronal fate (29, 30) . Astrocytes isolated from nonneurogenic brain regions, in contrast, produce factors that are inhibitory for adult neurogenesis (31) . Consistent with these reports, our experiments using cocultures of astrocytes and neural progenitors, both isolated from nonneurogenic brain regions, suggest that mature astrocytes outside of the SVZ and SGZ present a nonpermissive niche that actively inhibits adult neurogenesis. We have then identified ephrin-A2 and -A3 as key inhibitors associated with nonneurogenic astrocytes for adult neurogenesis. Whereas ephrin-A2 and -A3 are membrane-bound proteins, neural stem cells and neurospheres do constantly interact and make direct contact with feeder cells under the coculturing condition described in the present study. Nevertheless, we may not rule out the possibility that nonneurogenic astrocytes also release soluble inhibitory factors that can prevent progenitor cell proliferation and neural differentiation without requiring cell-cell contact. Further studies will be required to prove this notion. The present study reinforces the emerging view that regionally specified astrocytes have an active regulatory role in controlling neurogenesis and regeneration in the adult (8) .
Ephrins and Ephs are pivotal regulators of CNS development, including axon guidance, neural migration and patterning, synapse formation and vascular morphogenesis (32) (33) (34) (35) (36) . Recent studies point to a new role of ephrins in neural progenitor cell proliferation and migration in the developing CNS as well as in the SVZ of adult mice (13, 14, 37) . Both ephrins and Eph family receptor tyrosine kinases are known to be expressed by neural progenitors (13, 38) . Signaling mechanisms for ephrins have been difficult to characterize, partly because of ephrins' mediation of a bidirectional signaling (39) . Recent studies have demonstrated a proapoptotic effect of ephrins without affecting the proliferation of embryonic cortical progenitors (13) whereas EphA7 in the adult SVZ triggers a direct antiproliferative activity by mediating ephrin-A2-dependent reverse signaling (14) . Our experiments using a truncated, dominantnegative form of EphA7 strongly suggest that ephrin-A2 and -A3 evoke an EphA7 forward signaling pathway to regulate progenitor proliferation. These studies collectively illustrate a diverse mechanism of ephrin function and selective activation of intracellular events depending on the cellular context.
Proliferation of neural progenitor cells increases in single knockout mice lacking either ephrin-A2 or -A3, suggesting a redundant function for these two molecules. It is likely that not all of the newborn neurons of the mutant mice integrate and survive; rather, some of them are likely to undergo cell apoptosis. However, we were unable to detect significant differences in number of TUNEL ϩ cells between brain sections of WT and mutant mice (although there was probably a tendency of 15-20% increase in mutant mouse brains). In agreement with the previous report (15) , our investigation of neonatal A2 Ϫ/Ϫ A3 Ϫ/Ϫ mice revealed no developmental defects in cortical progenitor proliferation and neuro-or gliogenesis. Consistently, the signals of ephrin-A2 and -A3 are not detectable in embryonic or newborn mouse brains, but appear in the mouse neocortex after P4 (15, 28) . Together, these data suggest a specific role for ephrin-A2 and -A3 in postnatal neurogenesis.
It is likely that positive and negative growth signals act in conjunction to determine the fate of neural progenitors in vivo, and that absence of any of these proteins can result in an imbalance in the environmental inhibition of proliferation, leading to adult neurogenesis. In the SGZ and SVZ, a number of factors, such as Wnt, Notch, bone morphogenic protein, and sonic hedgehog, which are known to support progenitor proliferation and neurogenesis, persist into adulthood (16, 22, (34) (35) (36) . In agreement with these reports, we noted that niche astrocytes not only allows, but also produce growth-stimulating signals such as sonic hedgehog that actively stimulate sphere formation in cultures prepared from nonneurogenic brain regions or in the neocortex of adult mice in vivo (40) . In support of these findings, inflammation and reactive astrocytosis caused by disease or injury have been shown to result in changes in ephrin and Eph receptor expression as well as the production of factors that seem to either positively or negatively influence neurogenesis in the adult CNS (41) .
In summary, the results herein establish a previously undescribed mechanism for the regulation of neurogenesis and identify the ephrinA/EphA system as an endogenous modulator of neurogenesis in the adult CNS. It may thus be possible to stimulate neurogenesis from endogenous neural progenitors in diverse CNS regions. These results provide a new therapeutic avenue toward future neuronal cell replacement therapy for neurodegenerative diseases and injury.
Experimental Procedures
Animals. GFP transgenic mice driven under a chicken ␤-actin promoter were courtesy of M. Okabe (Osaka University, Osaka, Japan) (16) . GFAP-GFP mice were purchased from the The Jackson Laboratory (17) . A2 Ϫ/Ϫ , A3 Ϫ/Ϫ , and A2 Ϫ/Ϫ A3 Ϫ/Ϫ mice were generated as described in refs. 23 and 24. Mice older than 2 months are referred to as adult.
Immunohistochemistry. Procedures of immunohistochemistry were performed as described. Primary antibodies used included rat anti-BrdU (1:100; Novus Biologicals), mouse monoclonal antibodies specific for Ki67, DCX, and ␤III-tubulin (1:100; BD Biosciences), nestin (1:100; Abcam), ephrin-A2 or -A3 (Santa Cruz Biotechnology), MAP2, NeuN, HuD, andf RIP (1:200; Chemicon), O4 and GFAP (1:2,000; Sigma), and rabbit anti-S100 (1:300; Labvision), and secondary antibodies conjugated to either fluorescein (Vector Laboratories), Cy2, Cy3, or Cy5 (Jackson ImmunoResearch). TUNEL assays were performed according to the manufacturer's instructions (Roche Diagnostics).
Neural Progenitor Cell Culture and Differentiation. Isolation of stem cells from the CNS of adult mice was performed as described in ref. 42 (SI Experimental Procedures) . In some studies, primary astrocytes were cultured as described in ref. 8 . Astrocytes from adult GFAP-GFP mice were sorted by FACS and plated in the same well with dissociated brain cells. EphA7-T1 cDNA, isolated by screening a mouse cDNA library (Invitrogen), was cloned into pcDNA3 (Invitrogen). Neural stem cells were transfected by using electroporation (Amaxa) with the Nucleofector technology. After 3 days, cells were treated with clustered ephrin-A2 or ephrin-A3, and lysates were collected for Western blot analysis.
In Vivo Quantification. Adult mice received daily injections (i.p.) of BrdU (50 mg/kg) for 3-7 consecutive days or until killing. Four to 14 days after the first BrdU injection, mice were killed, and brain sections were double immunolabeled with rat anti-BrdU (1:100; Novus Biologicals) and other antibodies. At least 8,000 cells, distributed across four sections, were counted for each brain. Brain area was measured by using NIH Image software. Neuronal and glial cells were labeled by primary antibodies against neuronal markers or glial markers and then counted. Five sections per animal (total of five mice) were counted.
